The role of immunodeficiency in the pathogenesis of secondary lymphomas and leukemias
Silobrcić, V.
Lijecnicki Vjesnik 105(2-3): 111-113
1983
ISSN/ISBN: 0024-3477 PMID: 6855424 Document Number: 201653
Document emailed within 1 workday
Related Documents
Misset, J.L.; Mathé, G.; Gastiaburu, J.; Goutner, A.; Dorval, T.I.; Gouveia, J.; Hayat, M.; Jasmin, C.; Schwarzenberg, L.; Machover, D.; Ribaud, P.; de Vassal, F.; Horoszewicz, J.P. 1982: Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route Biomedicine and PharmacoTherapy 36(3): 167-170Cimino, G.; Rapanotti, M.C.; Biondi, A.; Elia, L.; Lo Coco, F.; Price, C.; Rossi, V.; Rivolta, A.; Canaani, E.; Croce, C.M.; Mandelli, F.; Greaves, M. 1997: Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias Cancer Research 57(14): 2879-2883
York, J.C.; Glick, A.D.; Collins, R.D. 1982: Unclassified leukemias and lymphomas Seminars in Oncology 9(4): 497-503
Robinson, D.; Liu, J.L.; Jones, D.; Brunovskis, P.; Qian, Z.; Isfort, R.; Tillotson, J.K.; Lee, L.; Witter, R.; Salter, D.; Crittenden, L.; Hughes, S.; Kung, H.J. 1997: Avian leukemias and lymphomas: interplay between retroviruses and herpesviruses Leukemia 11(Suppl 3): 176-178
Kondrat'eva, N.A.; Gershanovich, M.L.; Kondrat'ev, V.B.; Lebedev, V.N.; Vygovskaia, I.I. 1981: Use of VM 26 (epipodophyllotoxin) in treating acute leukemias and lymphomas in the adult Problemy Gematologii i Perelivaniia Krovi 26(7): 10-14
Soler, J.; Baiget, M.; Rubiol, E.; Guañabens, C.; Nunes, V.; Estivill, X.; Bosch, M.A. 1988: Genotype study of T receptors in the diagnosis and classification of leukemias and lymphomas Medicina Clinica 91(4): 135-138
Sellier, N.; Lalande, G.; Guérin, I.; Bennet, J. 1986: Unusual neurologic complications of treated lymphomas and leukemias in children Annales de Radiologie 29(3-4): 339-344
Brandt, L. 1982: The importance of environmental factors for etiology of leukemias, myelomas and malignant lymphomas Lakartidningen 79(15): 1490-1492
Gluzman, D.F.; Sklyarenko, L.M.; Nadgornaya, V.A.; Zavelevich, M.P.; Poludnenko, L.Y.; Ivanovskaya, T.S.; Koval, S.V.; Simonet, M.L. 2006: Structure of leukemias and lymphomas in children of Ukraine in post-Chernobyl period Experimental Oncology 28(2): 172-174
Ge, B.-j.; Chen, X.-m.; Yang, C.-q.; Wu, J. 2008: Role of secondary lymphoid tissue chemokine in the pathogenesis of rat ulcerative colitis Zhonghua Wei Chang Wai Ke Za Zhi 11(6): 561-564
Danieli, G.; Malini, P.L.; Montroni, M.; Cremonini, G.; Lauria, F.; Tura, S. 1972: Immunity, leukemias and lymphomas. 3. Immune reactions in malignant granuloma in relationship to the clinical stage of the disease Giornale di Clinica Medica 53(4): 179-195
Delia, D.; Polli, N.; Borrello, M.G.; Fontanella, E.; Biassoni, D.; Morandi, F.; Cattoretti, G.; Orazi, A.; Della Porta, G.D. 1988: Mixed-lineage leukemias and phenotypic shifts occurring in relapsed cases of acute T lymphoblastic lymphomas Leukemia 2(12 Suppl): 192s-197s
Zdziarska, B.; Nowacki, P.; Millo, B. 1995: Dysfunction of the blood-brain barrier in patients with acute leukemias or lymphomas of high grade malignancy Acta Haematologica Polonica 26(3): 299-304
Tobinai, K.; Hirose, M.; Minato, K.; Shimoyama, M. 1982: The reaction specificity of various monoclonal antibodies against cultured cell lines derived from human leukemias and malignant lymphomas Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 45(5): 897-906
Mesárosová, A.; Hrivnáková, A.; Babusíková, O. 1995: A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas Neoplasma 42(6): 307-312
Leone, G.; Mele, L.; Pulsoni, A.; Equitani, F.; Pagano, L. 1999: The incidence of secondary leukemias Haematologica 84(10): 937-945
Jessen, P.; Nielsen, B.; Jensen, I.M.; Ellegaard, J.; Hokland, P. 1992: Granulocyte-macrophage colony-stimulating factor. Treatment of patients with highly malignant lymphomas and acute lymphoblastic leukemias after autologous bone marrow transplantation Ugeskrift for Laeger 154(52): 3754-3757
Vivanco Martínez, J.L.; López Pérez, J.; Melero Moreno, C.; Torres Valdivieso, M.J.; Palacios López, M.E.; Contra Gómez, T.; Martín Ramos, N.; Bernacer Borja, M.; Gil López, C.; Valverde Moreno, F. 1998: The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid) Anales Espanoles de Pediatria 49(6): 603-608
Inghirami, G.; Szabolcs, M.J.; Yee, H.T.; Corradini, P.; Cesarman, E.; Knowles, D.M. 1993: Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin's lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction Laboratory Investigation; A Journal of Technical Methods and Pathology 68(6): 746-757
Lessard, M.; Gervais, C.; Struski, S. 2003: Chromosomal abnormalities in secondary myelodysplastic syndromes and leukemias Pathologie-Biologie 51(6): 356-365